Skip to main content

Calian announces agreement to sell its U.S. commercial IT business to Trace3

OTTAWA, Ontario, Aug. 26, 2026 (GLOBE NEWSWIRE) — Calian Group Ltd. (“the Company”) (TSX: CGY), a mission-critical solutions company focused on defence, space, healthcare and other critical infrastructure sectors, today announced it has entered into a definitive agreement to sell its United States (U.S.) commercial IT business based in Houston, Texas, to Trace3, a leading […]

financialpost.com ·3h ago

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Business

Fort Technology Closes Acquisition of Logia USA – Fuel Integrity Solutions for Data Centers Company

Toronto, Ontario, Aug. 26, 2026 (GLOBE NEWSWIRE) — Fort Technology Inc. (Nasdaq: FRTT, TSXV: FORT) (“Fort” or the “Company”), today announced that on August 26, 2026, it has completed its previously…

3h ago ·financialpost.com

Western Railway’s Bardoli Goods Shed Achieves Milestone With First-Ever Outward Piecemeal Loading

Western Railway’s Bardoli Goods Shed in Mumbai Division commenced its first-ever outward goods loading under the Piecemeal Demand category, marking an important milestone in freight operations and…

3h ago ·freepressjournal.in

Nigerian National Petroleum Company increases fuel price

The Nigerian National Petroleum Company Limited, NNPCL, has increased its Premium Motor Spirit, PMS, pump price despite Dangote Refinery’s free petrol delivery initiative and falling crude oil prices.

3h ago ·thechronicle.com.gh

Hyundai Motor Targets 9% Profit Margin by 2030

Hyundai Motor Company cited hybrid vehicles as its most profitable powertrain, expressing confidence in achieving an operating profit margin of 9% or higher by 2030.

Hyundai Motor aims for 9% profit margin by 2030.
Hybrid vehicles crucial for achieving profit target.
Over 10 new hybrid models planned for North America by 2030.

3h ago ·businesskorea.co.kr

SK Biopharmaceuticals Licenses Opacalium in 1 Trillion-Won Deal

SK Biopharmaceuticals has strengthened its new epilepsy drug pipeline through an in-licensing (L/I) deal worth 1 trillion won (about $722 million).

SK Biopharmaceuticals in-licenses Opacalim from Biohaven for $722M
Company aims to become big biotech with blockbuster drugs
Opacalim targets potassium channel Kv7 for epilepsy treatment

3h ago ·businesskorea.co.kr

Dubai shared housing rules come into effect in bid to curb dangerous accommodation

A new law regulating shared accommodation in Dubai came into effect on Wednesday, introducing permits and occupancy controls as authorities move to tackle overcrowding and informal housing.

3h ago ·thenationalnews.com

More from Wednesday 26 August →